Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery

[1]  P. Meybohm,et al.  Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. , 2021, JAMA surgery.

[2]  S. Sanyal,et al.  Safety and efficacy of tranexamic acid in minimizing perioperative bleeding in extrahepatic abdominal surgery: meta-analysis , 2021, BJS open.

[3]  R. Varadhan,et al.  Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses , 2020, Canadian Medical Association Journal.

[4]  Pavel S. Roshanov,et al.  Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. , 2020, British journal of anaesthesia.

[5]  J. Eikelboom,et al.  Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial , 2020, Pilot and Feasibility Studies.

[6]  G. Guyatt,et al.  Association between complications and death within 30 days after noncardiac surgery , 2019, Canadian Medical Association Journal.

[7]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[8]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[9]  R. Pearse,et al.  A Prospective International Multicentre Cohort Study of Intraoperative Heart Rate and Systolic Blood Pressure and Myocardial Injury After Noncardiac Surgery: Results of the VISION Study , 2017, Anesthesia and analgesia.

[10]  Publisher's Note , 2018, Anaesthesia.

[11]  Zongming Jiang,et al.  Optimal blood pressure decreases acute kidney injury after gastrointestinal surgery in elderly hypertensive patients: A randomized study: Optimal blood pressure reduces acute kidney injury. , 2017, Journal of clinical anesthesia.

[12]  S. Jaber,et al.  Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial , 2017, JAMA.

[13]  M. Grocott,et al.  Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery. , 2017, British journal of anaesthesia.

[14]  I. Chalmers,et al.  Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial , 2017, The Lancet.

[15]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[16]  A. Kappetein,et al.  Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. , 2018, The New England journal of medicine.

[17]  Dongsheng Yang,et al.  Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis , 2017, Anesthesiology.

[18]  Pavel S. Roshanov,et al.  Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort , 2017, Anesthesiology.

[19]  E. Mascha,et al.  Intraoperative Mean Arterial Pressure Variability and 30-day Mortality in Patients Having Noncardiac Surgery , 2015, Anesthesiology.

[20]  Ping Wang,et al.  Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials , 2015, European Journal of Orthopaedic Surgery & Traumatology.

[21]  Pavel S. Roshanov,et al.  Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial. , 2014, JAMA.

[22]  G. Guyatt,et al.  Clonidine in patients undergoing noncardiac surgery. , 2014, The New England journal of medicine.

[23]  G. Guyatt,et al.  Aspirin in patients undergoing noncardiac surgery. , 2014, The New England journal of medicine.

[24]  A. Garg,et al.  Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery: Toward an Empirical Definition of Hypotension , 2013, Anesthesiology.

[25]  Zhi-jun Li,et al.  Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials , 2013, European Spine Journal.

[26]  H. Kamel,et al.  Association Between Major Perioperative Hemorrhage and Stroke or Q-Wave Myocardial Infarction , 2012, Circulation.

[27]  Phil Edwards,et al.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.

[28]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[29]  S. Pocock,et al.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.

[30]  Haoran Zhang,et al.  The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

[31]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[32]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[33]  Xin Sun,et al.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.

[34]  J. Douketis,et al.  Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. , 2009, Thrombosis research.

[35]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[36]  U. Schirmer,et al.  Zur perioperativen Gabe von ACE-Hemmern , 2007, Der Anaesthesist.

[37]  D. Reich,et al.  Intraoperative Tachycardia and Hypertension Are Independently Associated with Adverse Outcome in Noncardiac Surgery of Long Duration , 2002, Anesthesia and analgesia.

[38]  P. Coriat,et al.  Should the Angiotensin II Antagonists be Discontinued Before Surgery? , 2001, Anesthesia and analgesia.

[39]  J. Sear,et al.  Predictors of postoperative myocardial ischaemia  The role of intercurrent arterial hypertension and other cardiovascular risk factors , 1997, Anaesthesia.

[40]  P. Coriat,et al.  Influence of Chronic Angiotensin‐converting Enzyme Inhibition on Anesthetic Induction , 1994, Anesthesiology.

[41]  J. Gold,et al.  Intraoperative blood pressure. What patterns identify patients at risk for postoperative complications? , 1990, Annals of surgery.